Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Following MicroRNAs Through the Cancer Metastatic Cascade.

Grisard E, Nicoloso MS.

Int Rev Cell Mol Biol. 2017;333:173-228. doi: 10.1016/bs.ircmb.2017.04.005. Epub 2017 Jun 7. Review.

PMID:
28729025
2.

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.

Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA.

Genome Biol. 2017 May 24;18(1):98. doi: 10.1186/s13059-017-1224-0.

3.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Dec 22;7(12):e2526. doi: 10.1038/cddis.2016.448. No abstract available.

4.

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.

Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA.

Clin Cancer Res. 2017 Jun 1;23(11):2891-2904. doi: 10.1158/1078-0432.CCR-16-1025. Epub 2016 Nov 30.

5.

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Cesaratto L, Grisard E, Coan M, Zandonà L, De Mattia E, Poletto E, Cecchin E, Puglisi F, Canzonieri V, Mucignat MT, Zucchetto A, Stocco G, Colombatti A, Nicoloso MS, Spizzo R.

Cell Death Dis. 2016 Sep 22;7(9):e2374. doi: 10.1038/cddis.2016.278. Erratum in: Cell Death Dis. 2016 Dec 22;7(12 ):e2526.

6.

Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.

Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B.

Oncogene. 2016 Sep 15;35(37):4914-26. doi: 10.1038/onc.2016.23. Epub 2016 Feb 15.

7.

The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.

Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gafà R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS.

Gut. 2016 Jun;65(6):977-989. doi: 10.1136/gutjnl-2015-309372. Epub 2015 Mar 24.

8.

Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.

Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SA.

Sci Rep. 2013;3:2687. doi: 10.1038/srep02687.

9.

HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts.

Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GA.

Cell Death Differ. 2013 Dec;20(12):1675-87. doi: 10.1038/cdd.2013.119. Epub 2013 Sep 13.

10.

Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.

Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, Nicoloso MS, Wu SY, Almeida MI, Bottsford-Miller J, Pecot CV, Zand B, Matsuo K, Shahzad MM, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Calin GA.

Cancer Discov. 2013 Nov;3(11):1302-15. doi: 10.1158/2159-8290.CD-13-0159. Epub 2013 Sep 3.

11.

Coordinated targeting of the EGFR signaling axis by microRNA-27a*.

Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY.

Oncotarget. 2013 Sep;4(9):1388-98.

12.

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.

Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA.

Genome Res. 2013 Sep;23(9):1446-61. doi: 10.1101/gr.152942.112. Epub 2013 Jun 24.

13.

Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.

Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RC Jr.

PLoS One. 2012;7(7):e41170. doi: 10.1371/journal.pone.0041170. Epub 2012 Jul 19.

14.

Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.

Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA.

Gastroenterology. 2012 Apr;142(4):886-896.e9. doi: 10.1053/j.gastro.2011.12.047. Epub 2012 Jan 10.

15.

p63-microRNA feedback in keratinocyte senescence.

Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, Saintigny G, Dellambra E, Odorisio T, Mahé C, Calin GA, Candi E, Melino G.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1133-8. doi: 10.1073/pnas.1112257109. Epub 2012 Jan 6.

16.

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM.

JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.

17.

miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.

Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti C Jr, Tirapelli D, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu MM, Zhang W, Puduvalli V, Calin GA.

Genes Chromosomes Cancer. 2010 Nov;49(11):981-90. doi: 10.1002/gcc.20808.

18.

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.

Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps TJ, Plunkett W, Coombes KR, Abruzzo LV, Keating MJ, Calin GA.

Blood. 2010 Aug 12;116(6):945-52. doi: 10.1182/blood-2010-01-263889. Epub 2010 Apr 14.

19.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

20.

p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.

Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F, Schiappacassi M, D'Andrea S, Nicoloso MS, Lovisa S, Sonego M, Defilippi P, Vecchione A, Colombatti A, Friedl P, Baldassarre G.

Mol Cell Biol. 2010 May;30(9):2229-40. doi: 10.1128/MCB.00723-09. Epub 2010 Mar 1.

21.

Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.

Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.

Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12.

22.

Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.

Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM, Calin GA.

Carcinogenesis. 2010 Feb;31(2):208-15. doi: 10.1093/carcin/bgp209. Epub 2009 Nov 19.

23.

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.

Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P.

Cancer Res. 2009 Dec 1;69(23):9090-5. doi: 10.1158/0008-5472.CAN-09-2552. Epub 2009 Nov 10.

24.

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.

Santarpia L, Nicoloso M, Calin GA.

Endocr Relat Cancer. 2010 Jan 29;17(1):F51-75. doi: 10.1677/ERC-09-0222. Print 2010 Mar. Review.

25.

MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.

Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA.

PLoS One. 2009 Oct 12;4(10):e7405. doi: 10.1371/journal.pone.0007405.

26.

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.

Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GA.

Cell Death Differ. 2010 Feb;17(2):246-54. doi: 10.1038/cdd.2009.117. Epub 2009 Sep 4.

27.

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.

Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C.

Clin Cancer Res. 2009 Aug 15;15(16):5060-72. doi: 10.1158/1078-0432.CCR-08-2245. Epub 2009 Aug 11.

28.

MicroRNAs and cancer--new paradigms in molecular oncology.

Negrini M, Nicoloso MS, Calin GA.

Curr Opin Cell Biol. 2009 Jun;21(3):470-9. doi: 10.1016/j.ceb.2009.03.002. Epub 2009 May 4. Review.

PMID:
19411171
29.

SnapShot: MicroRNAs in Cancer.

Spizzo R, Nicoloso MS, Croce CM, Calin GA.

Cell. 2009 May 1;137(3):586-586.e1. doi: 10.1016/j.cell.2009.04.040. No abstract available.

30.

MicroRNAs--the micro steering wheel of tumour metastases.

Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA.

Nat Rev Cancer. 2009 Apr;9(4):293-302. doi: 10.1038/nrc2619. Epub 2009 Mar 5. Review.

PMID:
19262572
31.

MicroRNAs: new players in AML pathogenesis.

Nicoloso MS, Jasra B, Calin GA.

Cancer Treat Res. 2010;145:169-81. doi: 10.1007/978-0-387-69259-3_10. Review. No abstract available.

PMID:
20306251
32.

A microRNA DNA methylation signature for human cancer metastasis.

Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61. doi: 10.1073/pnas.0803055105. Epub 2008 Sep 3.

33.

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.

Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A.

Cancer Cell. 2008 Mar;13(3):272-86. doi: 10.1016/j.ccr.2008.02.013.

34.

Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.

Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, Canzonieri V, D'Andrea S, Zucchetto A, Friedl P, Colombatti A, Baldassarre G.

Mol Biol Cell. 2008 May;19(5):2003-13. doi: 10.1091/mbc.E07-09-0894. Epub 2008 Feb 27.

35.

MicroRNAs as new biomarkers in oncology.

Spizzo R, Nicoloso MS, Calin GA.

Expert Opin Med Diagn. 2008 Feb;2(2):115-27. doi: 10.1517/17530059.2.2.115.

PMID:
23485132
36.

MicroRNA involvement in brain tumors: from bench to bedside.

Nicoloso MS, Calin GA.

Brain Pathol. 2008 Jan;18(1):122-9. doi: 10.1111/j.1750-3639.2007.00119.x. Review.

PMID:
18226107
37.

MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.

Nicoloso MS, Kipps TJ, Croce CM, Calin GA.

Br J Haematol. 2007 Dec;139(5):709-16. Review.

PMID:
18021085
38.

Association of Wwox with ErbB4 in breast cancer.

Aqeilan RI, Donati V, Gaudio E, Nicoloso MS, Sundvall M, Korhonen A, Lundin J, Isola J, Sudol M, Joensuu H, Croce CM, Elenius K.

Cancer Res. 2007 Oct 1;67(19):9330-6.

39.

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

Vecchione A, Baldassarre G, Ishii H, Nicoloso MS, Belletti B, Petrocca F, Zanesi N, Fong LY, Battista S, Guarnieri D, Baffa R, Alder H, Farber JL, Donovan PJ, Croce CM.

Cancer Cell. 2007 Mar;11(3):275-89.

40.

Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.

Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM.

Cancer Res. 2006 Nov 1;66(21):10287-91.

41.

Prostaglandin E2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line.

Biondi C, Ferretti ME, Pavan B, Lunghi L, Gravina B, Nicoloso MS, Vesce F, Baldassarre G.

Placenta. 2006 Jun-Jul;27(6-7):592-601. Epub 2005 Sep 12.

PMID:
16159661
42.

p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

Belletti B, Nicoloso MS, Schiappacassi M, Chimienti E, Berton S, Lovat F, Colombatti A, Baldassarre G.

Curr Med Chem. 2005;12(14):1589-605. Review.

PMID:
16022660
43.

HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.

Baldassarre G, Belletti B, Battista S, Nicoloso MS, Pentimalli F, Fedele M, Croce CM, Fusco A.

Oncogene. 2005 Oct 13;24(45):6809-19.

PMID:
16007157
44.

Evaluation of the efficacy of a bismuth shield during CT examinations.

Colombo P, Pedroli G, Nicoloso M, Re S, Valvassori L, Vanzulli A.

Radiol Med. 2004 Nov-Dec;108(5-6):560-8. English, Italian.

PMID:
15723002
45.

p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A.

Cancer Cell. 2005 Jan;7(1):51-63.

46.

Linking inflammation to cell cycle progression.

Baldassarre G, Nicoloso MS, Schiappacassi M, Chimienti E, Belletti B.

Curr Pharm Des. 2004;10(14):1653-66. Review.

PMID:
15134563
47.

Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides.

Cavaillé J, Nicoloso M, Bachellerie JP.

Nature. 1996 Oct 24;383(6602):732-5.

PMID:
8878486
49.
50.

Novel intron-encoded small nucleolar RNAs with long sequence complementarities to mature rRNAs involved in ribosome biogenesis.

Bachellerie JP, Nicoloso M, Qu LH, Michot B, Caizergues-Ferrer M, Cavaille J, Renalier MH.

Biochem Cell Biol. 1995 Nov-Dec;73(11-12):835-43. Review.

PMID:
8721999

Supplemental Content

Loading ...
Support Center